Three's company: Component structures bring a closer view of tripartite drug efflux pumps

Current Opinion in Structural Biology

Volumn 14, Issue 6, 2004, Pages 741-747

  Eswaran, Jeyanthy ^a   Koronakis, Eva ^a   Higgins, Matthew K ^a   Hughes, Colin ^a   Koronakis, Vassilis ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRB PROTEIN; POLYPEPTIDE; PROTEIN; TOLC PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BACTERIAL INFECTION; BACTERIAL MEMBRANE; DRUG BINDING SITE; METAL BINDING; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; CELL MEMBRANE; ESCHERICHIA COLI PROTEINS; HUMANS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MODELS, MOLECULAR; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS); PROKARYOTA;

EID: 9944247705     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2004.10.003     Document Type: Review

References (39)

1. I.T. Paulsen, J.H. Park, P.S. Choi, and M.H. Saier Jr A family of Gram-negative bacterial outer membrane factors that function in the export of proteins, carbohydrates, drugs and heavy metals FEMS Microbiol Lett 156 1997 1 8
2. V. Koronakis, J. Eswaran, and C. Hughes Structure and function of TolC: the bacterial exit duct for proteins and drugs Annu Rev Biochem 73 2004 467 489
3. D.G. Thanassi, and S.J. Hultgren Multiple pathways allow protein secretion across the bacterial outer membrane Curr Opin Cell Biol 12 2000 420 430
4. T. Dinh, T. Paulsen, and M.H. Saier Jr A family of extra-cytoplasmic proteins that allow transport of large molecules across the outer membranes of Gram-negative bacteria J Bacteriol 176 1994 3825 3831
5. J.M. Johnson, and G.M. Church Alignment and structure prediction of divergent protein families: periplasmic and outer membrane proteins of bacterial efflux pumps J Mol Biol 287 1999 695 715
6. C. Andersen, C. Hughes, and V. Koronakis Chunnel vision: export and efflux through bacterial channel-tunnels EMBO Rep 1 2000 313 318
7. M.H. Saier, I.T. Paulsen, M.K. Sliwinski, S.S. Pao, R.A. Skurray, and H. Nikaido Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria FASEB J 12 1998 265 274
8. R.E. Hancock, and F.S. Brinkman Function of Pseudomonas porins in uptake and efflux Annu Rev Microbiol 56 2002 17 38
9. M.C. Sulavik, C. Houseweart, C. Cramer, N. Jiwani, N. Murgolo, J. Greene, B. DiDomenico, K.J. Shaw, G.H. Miller, R. Hare, and G. Shimer Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes Antimicrob Agents Chemother 45 2001 1126 1136
10. H.I. Zgurskaya, and H. Nikaido Multidrug resistance mechanisms: drug efflux across two membranes Mol Microbiol 37 2000 219 225
11. S. Murakami, R. Nakashima, E. Yamashita, and A. Yamaguchi Crystal structure of bacterial multidrug efflux transporter AcrB Nature 419 2002 587 593 The three-dimensional structure of the RND class proton antiporter AcrB, the integral IM component of the major E. coli drug efflux system, indicates a possible proton translocation pathway through the membrane and allows speculation on how substrates gain access to the efflux machinery. The trimeric AcrB structure is used in this review to present a preliminary model of the assembled drug pump.
12. S. Murakami, and A. Yamaguchi Multidrug-exporting secondary transporters Curr Opin Struct Biol 13 2003 443 452
13. V. Koronakis, A. Sharff, E. Koronakis, B. Luisi, and C. Hughes Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export Nature 405 2000 914 919 The structure of the OM protein TolC revised perceptions of the structure and function of efflux pumps, and is the core of the preliminary model presented in this review. In the novel TolC fold, a change in superhelical twist of the 100 Å long α helices determines the tapering and closure of the periplasmic cylinder. This finding established the basis for subsequent studies of the opening mechanism and the electrophysiological properties of the membrane channel.
14. V. Koronakis, C. Andersen, and C. Hughes Channel-tunnels Curr Opin Struct Biol 11 2001 403 407
15. C.R. Calladine, A. Sharff, and B. Luisi How to untwist an alpha-helix: structural principles of an alpha-helical barrel J Mol Biol 305 2001 603 618
16. R. Benz, E. Maier, and I. Gentschev TolC of Escherichia coli functions as an outer membrane channel Zentralbl Bakteriol 278 1993 187 196
17. C. Andersen, C. Hughes, and V. Koronakis Electrophysiological behaviour of the TolC channel-tunnel J Membr Biol 185 2002 83 92
18. M.K. Higgins, E. Bokma, E. Koronakis, C. Hughes, and V. Koronakis Structure of the periplasmic component of a bacterial drug efflux pump Proc Natl Acad Sci USA 101 2004 9994 9999 The structure of the third essential component of tripartite drug efflux pumps, the 'adaptor protein', postulated to bridge the IM and OM pump subunits. A possible oligomeric structure is presented, derived from the observed packing in the crystal. The adaptor protein MexA from P. aeruginosa is closely related to AcrA of E. coli and its structure is therefore included in this review to depict a possible model of the complete pump assembly.
19. ••]. Two alternative options for assembly in the complete drug pump are presented: one a wrap-around version of the adaptor oligomer, as seen in the crystal spiral-arc, the other suggesting that three dimers of MexA interact with the periplasmic helices of the OprM exit duct, the structure of which is modelled from that of TolC.
20. A. Berg, J. Vervoort, and A. de Kok Three-dimensional structure in solution of the N-terminal lipoyl domain of the pyruvate dehydrogenase complex from Azotobacter vinelandii Eur J Biochem 244 1997 352 360
21. M. Ingelman, V. Bianchi, and H. Eklund The three-dimensional structure of flavodoxin reductase from Escherichia coli at 1.7 Å resolution J Mol Biol 268 1997 147 157
22. F. Vincent, S. Spinelli, R. Ramoni, S. Grolli, P. Pelosi, C. Cambillau, and M. Tegoni Complexes of porcine odorant binding protein with odorant molecules belonging to different chemical classes J Mol Biol 300 2000 127 139
23. G.D. Van Duyne, R.F. Standaert, P.A. Karplus, S.L. Schreiber, and J. Clardy Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex Science 252 1991 839 842
24. K.M. Ferguson, M.A. Lemmon, J. Schlessinger, and P.B. Sigler Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain Cell 83 1995 1037 1046
25. T. Thanabalu, E. Koronakis, C. Hughes, and V. Koronakis Substrate-induced assembly of a contiguous channel for protein export from E. coli: reversible bridging of an inner-membrane translocase to an outer membrane exit pore EMBO J 17 1998 6487 6496
26. T. Touze, J. Eswaran, E. Bokma, E. Koronakis, C. Hughes, and Koronakis V Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system Mol Microbiol 53 2004 697 706 The first demonstration, by in vivo cross-linking, that the E. coli drug efflux proteins AcrA, AcrB and TolC assemble into a tripartite complex in vivo, similar to the previously reported TolC-HlyB-HlyD protein export system [25]. AcrA-AcrB-TolC assembly appeared constitutive rather than reversible. Underlying bilateral contacts of component proteins were analysed by in vivo cross-linking and their interaction characteristics analysed by ITC. This revealed limitations of cross-linking analyses and indicated complexity of the component interaction patterns.
27. S. Narita, S. Eda, E. Yoshihara, and T. Nakae Linkage of the efflux-pump expression level with substrate extrusion rate in the MexAB-OprM efflux pump of Pseudomonas aeruginosa Biochem Biophys Res Commun 308 2003 922 926
28. C.A. Elkins, and H. Nikaido Chimeric analysis of AcrA function reveals the importance of its C-terminal domain in its interaction with the AcrB multidrug efflux pump J Bacteriol 185 2003 5349 5356
29. H.I. Zgurskaya, and H. Nikaido Cross-linked complex between oligomeric periplasmic lipoprotein AcrA and the inner-membrane-associated multidrug efflux pump AcrB from Escherichia coli J Bacteriol 182 2000 4264 4267
30. H. Ip, K. Stratton, H. Zgurskaya, and J. Liu pH-induced conformational changes of AcrA, the membrane fusion protein of Escherichia coli multidrug efflux system J Biol Chem 278 2003 50474 50482
31. E.W. Yu, G. McDermott, H. Zgurskaya, H. Nikaido, and D.E. Koshland Jr Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump Science 300 2003 976 980
32. K.M. Pos, A. Schiefner, M.A. Seeger, and K. Diederichs Crystallographic analysis of AcrB FEBS Lett 564 2004 333 339
33. J.K. Middlemiss, and K. Poole Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa J Bacteriol 186 2004 1258 1269
34. W. Mao, M.S. Warren, D.S. Black, T. Satou, T. Murata, T. Nishino, N. Gotoh, and O. Lomovskaya On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition Mol Microbiol 46 2002 889 901
35. L. Balakrishnan, C. Hughes, and V. Koronakis Substrate-triggered recruitment of the TolC channel-tunnel during type I export of hemolysin by Escherichia coli J Mol Biol 313 2001 501 510
36. C. Andersen, E. Koronakis, E. Bokma, J. Eswaran, D. Humphreys, C. Hughes, and Koronakis V Transition to the open state of the TolC periplasmic tunnel entrance Proc Natl Acad Sci USA 99 2002 11103 11108
37. J. Eswaran, C. Hughes, and V. Koronakis Locking TolC entrance helices to prevent protein translocation by the bacterial type I export apparatus J Mol Biol 327 2003 309 315
38. C. Andersen, E. Koronakis, C. Hughes, and V. Koronakis An aspartate ring at the TolC tunnel entrance determines ion selectivity and presents a target for blocking by large cations Mol Microbiol 44 2002 1131 1139 This study used protein reconstituted in black lipid bilayers to identify a high-affinity metal-binding site located at the TolC entrance constriction. The site is determined by six aspartate residues that form a highly electronegative 'gate'. A series of divalent and trivalent cations were shown to bind with nanomolar affinities and, in one case, cause irreversible blocking of the TM pore.
39. M. Higgins, J. Eswaran, P. Edwards, G. Schertler, C. Hughes, and V. Koronakis Structure of the ligand-blocked periplasmic entrance of the bacterial multidrug efflux protein TolC J Mol Biol 342 2004 697 702